Personal information

Verified email addresses

Chemistry Clinical Biochemistry Molecular Diagnostics Cancer Research Liquid Biopsy
Greece

Biography

•Research Scientist, Department of Clinical Therapeutics Laboratory, School of Medicine, National and Kapodistrian University of Athens

•MSc in Clinical Biochemistry, Molecular Diagnostics, Analysis of Circulating Tumor Cells Laboratory, National and Kapodistrian University of Athens

•Chemist (BSc) National and Kapodistrian University of Athens

Activities

Employment (2)

Plasma Cell Dyscrasias Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece: Athens, Attica, GR

2023-09-04 to present | Research Scientist (Department of Clinical Therapeutics Research Laboratory)
Employment
Source: Self-asserted source
Ioannis (John) Kollias

Hellenic Institute for the Study of Sepsis: Chaidari, Attica, GR

2022-06-01 to 2023-08-31 | Research Scientist (4th Department of Internal Medicine, Attikon University General Hospital)
Employment
Source: Self-asserted source
Ioannis (John) Kollias

Education and qualifications (2)

National and Kapodistrian University of Athens: Athens, Attiki, GR

2019-10 to 2022-05 | MSc Clinical Biochemistry/ Molecular Diagnostics (Biology)
Education
Source: Self-asserted source
Ioannis (John) Kollias

National and Kapodistrian University of Athens: Athens, Greece, GR

2014-10-01 to 2018-09-01 | BSc (Hons) (Chemistry)
Education
Source: Self-asserted source
Ioannis (John) Kollias

Works (5)

P-I-0133: Technical repeatability and efficiency in proteomics: a comparative study of various biological matrices

23rd Human Proteome Organization World Congress
2024-10-23 | Conference poster
Contributors: Ioannis (John) Kollias
Source: Self-asserted source
Ioannis (John) Kollias

P318 Gut microbiome as a risk factor for mortality among sepsis patients of extreme severity

42nd International Symposium on Intensive Care & Emergency Medicine
2023-03-21 | Conference poster
Part of ISSN: 1364-8535
Source: Self-asserted source
Ioannis (John) Kollias

DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection

Clinical Epigenetics
2022-12 | Journal article
Part of ISSN: 1868-7075
Part of ISSN: 1868-7083
Source: Self-asserted source
Ioannis (John) Kollias

Metabolism-Related Gene Expression in Circulating Tumor Cells from Patients with Early Stage Non-Small Cell Lung Cancer

Cancers MDPI
2022-06-30 | Journal article
Source: Self-asserted source
Ioannis (John) Kollias
grade
Preferred source (of 3)‎

Abstract 3384: Combined DNA methylation analysis in size based CTC fraction and matched plasma-cfDNA provides prognostic information in early stage NSCLC

Cancer Research
2022-06-15 | Journal article
Part of ISSN: 1538-7445
Contributors: Athina N. Markou; Dora Londra; Victoria Tserpeli; John Kollias; Emilia Tsaroucha; Ioannis Pateras; K Potaris; Ioannis Vamvakaris; Athanasios Kotsakis; Vasilis Georgoulias et al.
Source: Self-asserted source
Ioannis (John) Kollias